| GRGTX | RMEBX | GRGTX / RMEBX | |
| Total Expense Ratio | 0.74 | 1.07 | 69% |
| Annual Report Gross Expense Ratio | 0.94 | 1.07 | 88% |
| Fund Existence | 18 years | 11 years | - |
| Gain YTD | 4.595 | 2.231 | 206% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 431M | 112B | 0% |
| Annual Yield % from dividends | 1.31 | 1.08 | 121% |
| Returns for 1 year | 3.96 | 7.30 | 54% |
| Returns for 3 years | 19.69 | 28.21 | 70% |
| Returns for 5 years | 28.44 | 43.15 | 66% |
| Returns for 10 years | 102.55 | 103.95 | 99% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TRWCX | 25.79 | -0.01 | -0.04% |
| Transamerica International Equity C | |||
| KSCOX | 171.44 | -0.08 | -0.05% |
| Kinetics Small Cap Opportunities No Load | |||
| RYOAX | 59.77 | -0.08 | -0.13% |
| Rydex Biotechnology H | |||
| CNPAX | 70.41 | -0.89 | -1.25% |
| American Funds New Perspective 529A | |||
| TCPWX | 12.21 | -0.33 | -2.63% |
| Transamerica Capital Growth R6 | |||